Lynx Biosciences

Series-A
lynx.bio Biotech & Healthcare San Diego, United States
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced Feb 7, 2025
Investors 10 Backers
Decision Makers 6 Available

About Lynx Biosciences

Lynx Biosciencesis a clinical-stage biotechnology company.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Diego, United States
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website lynx.bio
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @lynxbio (203 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  3. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

  4. Capital Raise

    Raised undisclosed · Seed

    Backed by Checkmate Capital

Investors & Backers

10
Checkmate Capital
Lead
Chorom Pak
Cove Fund
East Los Capital
EvoNexus
Great Oaks Venture Capital
Pasadena Angels
TCA Venture Group
WARF Ventures
Wisconsin Investment Partners

Funding History

4 Rounds
Series-A equity · Feb 7, 2025
Series-A equity · Nov 16, 2023
Series-A equity · May 25, 2022
Seed equity · Nov 3, 2021

Round backers: Checkmate Capital

Founders & Leadership

3

Benjamin Titz

VP, Corporate Development

Work email & phone locked Unlock →

Chorom Pak

Founder

Work email & phone locked Unlock →

Sylvaine Cases

Chief Business Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts